Published in FEBS Lett on June 30, 1997
The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor. Proc Natl Acad Sci U S A (2004) 2.04
Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68
Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl Environ Microbiol (1999) 1.66
Inactivation of the ciaH Gene in Streptococcus mutans diminishes mutacin production and competence development, alters sucrose-dependent biofilm formation, and reduces stress tolerance. Infect Immun (2004) 1.62
Bacteriocin diversity in Streptococcus and Enterococcus. J Bacteriol (2006) 1.57
Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes. Appl Environ Microbiol (2000) 1.53
The response regulator ComE in Streptococcus mutans functions both as a transcription activator of mutacin production and repressor of CSP biosynthesis. Microbiology (2007) 1.48
Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans. Infect Immun (1998) 1.46
Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl Environ Microbiol (2006) 1.35
Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: elucidation of the antimicrobial repertoire by genetic dissection. Appl Environ Microbiol (2005) 1.31
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biotechnol (2008) 1.22
Identification of nlmTE, the locus encoding the ABC transport system required for export of nonlantibiotic mutacins in Streptococcus mutans. J Bacteriol (2005) 1.21
MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob Agents Chemother (2000) 1.14
The mutacins of Streptococcus mutans: regulation and ecology. Mol Oral Microbiol (2011) 1.10
In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics (2010) 1.04
Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Appl Environ Microbiol (2002) 0.98
Replacement of trifluoroacetic acid with HCl in the hydrophobic purification steps of pediocin PA-1: a structural effect. Appl Environ Microbiol (2002) 0.94
The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol (2002) 0.93
Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91. Appl Microbiol Biotechnol (2012) 0.82
SmbFT, a putative ABC transporter complex, confers protection against the lantibiotic Smb in Streptococci. J Bacteriol (2013) 0.81
A conserved streptococcal membrane protein, LsrS, exhibits a receptor-like function for lantibiotics. J Bacteriol (2014) 0.79
Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1. BMC Microbiol (2011) 0.79
Mutacin H-29B is identical to mutacin II (J-T8). BMC Microbiol (2006) 0.79
Characterization of the Antimicrobial Peptide Penisin, a Class Ia Novel Lantibiotic from Paenibacillus sp. Strain A3. Antimicrob Agents Chemother (2015) 0.76
Mutacins of Streptococcus mutans. Braz J Microbiol (2011) 0.75
Inhibitory effect of obovatol from Magnolia obovata on the Salmonella type III secretion system. J Antibiot (Tokyo) (2017) 0.75
Massive gene decay in the leprosy bacillus. Nature (2001) 11.98
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20
Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice. Antimicrob Agents Chemother (1992) 3.72
Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology (2007) 2.59
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Multiplex polymerase chain reaction for detection and differentiation of the microbial insecticide Bacillus thuringiensis. Appl Environ Microbiol (1993) 1.96
Comparative analysis of the 16S to 23S ribosomal intergenic spacer sequences of Bacillus thuringiensis strains and subspecies and of closely related species. Appl Environ Microbiol (1995) 1.82
Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev (1998) 1.81
Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev (2012) 1.66
Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum Mol Genet (2000) 1.62
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin Microbiol Infect (2011) 1.55
Sugar Utilization and Acid Production by Free and Entrapped Cells of Streptococcus salivarius subsp. thermophilus, Lactobacillus delbrueckii subsp. bulgaricus, and Lactococcus lactis subsp. lactis in a Whey Permeate Medium. Appl Environ Microbiol (1989) 1.53
Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: a new progressive disorder due to diffuse cerebral microangiopathy. Neurology (1996) 1.53
Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis (1996) 1.35
Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis (2002) 1.32
Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Neurology (2006) 1.32
Identification of strains isolated as total and fecal coliforms and comparison of both groups as indicators of fecal pollution in tropical climates. Can J Microbiol (1983) 1.31
Comparative analysis of the exopolysaccharide biosynthesis gene clusters from four strains of Lactobacillus rhamnosus. Microbiology (2005) 1.29
Detection and activity of a bacteriocin produced by Leuconostoc mesenteroides. Appl Environ Microbiol (1991) 1.29
Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol (1994) 1.22
Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care (1995) 1.18
Preliminary characterization of four bacteriocins from Streptococcus mutans. Can J Microbiol (1990) 1.16
Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology (1998) 1.15
Multifocal neuropathy due to plasma cell infiltration of peripheral nerves in multiple myeloma. Neurology (2006) 1.14
MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob Agents Chemother (2000) 1.14
Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J Appl Microbiol (2003) 1.13
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain (2000) 1.13
Use of drugs of abuse in less than 30-year-old drivers killed in a road crash in France: a spectacular increase for cannabis, cocaine and amphetamines. Forensic Sci Int (2005) 1.10
[Microanalysis of plasma isoniazid and acetylisoniazid by high performance liquid chromatography]. J Chromatogr (1984) 1.10
Smoking cessation counseling practices of general practitioners in Montreal. Prev Med (2001) 1.10
3-hydroxypropionaldehyde: applications and perspectives of biotechnological production. Appl Microbiol Biotechnol (2003) 1.09
Identification and molecular characterization of the chromosomal exopolysaccharide biosynthesis gene cluster from Lactococcus lactis subsp. cremoris SMQ-461. Appl Environ Microbiol (2005) 1.08
Simple method of purification and sequencing of a bacteriocin produced by Pediococcus acidilactici UL5. J Appl Bacteriol (1994) 1.07
Immunodot detection of nisin Z in milk and whey using enhanced chemiluminescence. J Appl Microbiol (1998) 1.06
Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation. Ann Neurol (2000) 1.05
Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology (1999) 1.05
Production and utilization of polyclonal antibodies against nisin in an ELISA and for immuno-location of nisin in producing and sensitive bacterial strains. J Appl Microbiol (1999) 1.05
Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain (1996) 1.03
Bacteriology of the oral cavity of BALB/c mice. Can J Microbiol (1986) 1.03
Production of 3-hydroxypropionaldehyde using a two-step process with Lactobacillus reuteri. Appl Microbiol Biotechnol (2005) 1.02
The invasion route for an insect pest species: the tobacco aphid in the New World. Mol Ecol (2010) 1.01
Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension (1999) 1.00
Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect (2001) 1.00
Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects. Diabetes Metab (2003) 1.00
Molecular characterization of a theta replication plasmid and its use for development of a two-component food-grade cloning system for Lactococcus lactis. Appl Environ Microbiol (2001) 0.99
The Roussy-Lévy family: from the original description to the gene. Ann Neurol (1999) 0.99
Production of mutacin-like substances by Streptococcus mutans. Can J Microbiol (1989) 0.99
Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study. J Infect (2003) 0.99
Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis. Nephrol Dial Transplant (1994) 0.99
The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes (2011) 0.98
Multifocal deficits due to leukemic meningoradiculitis in chronic lymphocytic leukemia. J Neurol Sci (2008) 0.97
Production and characterization of anti-nisin Z monoclonal antibodies: suitability for distinguishing active from inactive forms through a competitive enzyme immunoassay. Appl Microbiol Biotechnol (2001) 0.97
Comparison of the functionality of exopolysaccharides produced in situ or added as bioingredients on yogurt properties. J Dairy Sci (2005) 0.97
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy. Eur J Neurol (2013) 0.95
Increasing incidence of Trichophyton tonsurans in Paris, France: a 15-year retrospective study. Br J Dermatol (2012) 0.95
In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacteria. Lett Appl Microbiol (2007) 0.95
Comparison of the proportions of oral bacterial species in BALB/c mice from different suppliers. Lab Anim (1996) 0.95
Effect of chelatants on gellan gel rheological properties and setting temperature for immobilization of living bifidobacteria. Biotechnol Prog (1993) 0.94
Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria. Antimicrob Agents Chemother (1992) 0.94
Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model. Microb Ecol (2004) 0.94
Consequences of metformin intoxication. Diabetes Care (1998) 0.93
[Critical study of ELISA technique and high sensitivity direct agglutination test for the screening of antitoxoplasma IgG]. Ann Biol Clin (Paris) (1991) 0.93
Inhibition of Listeria innocua in cheddar cheese by addition of nisin Z in liposomes or by in situ production in mixed culture. Appl Environ Microbiol (2002) 0.93
Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum (1995) 0.93
Exopolysaccharide production during batch cultures with free and immobilized Lactobacillus rhamnosus RW-9595M. J Appl Microbiol (2003) 0.92
No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice. Infect Immun (1996) 0.92
Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol (1991) 0.92
Evidence that mutacin II production is not mediated by a 5.6-kb plasmid in Streptococcus mutans. Plasmid (1990) 0.91
Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J Neuroendocrinol (2012) 0.91
Measurement of metformin concentration in erythrocytes: clinical implications. Diabetes Obes Metab (2003) 0.91
Vulnerability of nerve fibres to ischaemia. A quantitative light and electron microscope study. Brain (1991) 0.91
Comparison of the activity spectra against pathogens of bacterial strains producing a mutacin or a lantibiotic. Can J Microbiol (2001) 0.91
Fungal contamination of food in hematology units. J Clin Microbiol (2000) 0.91
Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin Infect Dis (2000) 0.90
High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia. Clin Microbiol Infect (2009) 0.89
Rapid discrimination among dermatophytes, Scytalidium spp., and other fungi with a PCR-restriction fragment length polymorphism ribotyping method. J Clin Microbiol (2001) 0.89
Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model. J Appl Microbiol (2009) 0.88
Note: genetic and biochemical characterization on nisin Z produced by Lactococcus lactis ssp. lactis biovar. diacetylactis UL 719. J Appl Microbiol (1997) 0.88
Application of inductively coupled plasma mass spectrometry multielement analysis in fingernail and toenail as a biomarker of metal exposure. J Anal Toxicol (2009) 0.87
Effects of mixed starter composition on nisin Z production by lactococcus lactis subsp. lactis biovar. diacetylactis UL 719 during production and ripening of Gouda cheese. Int J Food Microbiol (2000) 0.87
Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria. Antimicrob Agents Chemother (1996) 0.87
Physicians Taking Action Against Smoking: an intervention program to optimize smoking cessation counselling by Montreal general practitioners. CMAJ (2001) 0.87
[Cerebral complications of incontinentia pigmenti. A clinicopathological study of a case]. Rev Neurol (Paris) (1992) 0.86
Use of collagen-hydroxyethylmethacrylate hydrogels for cell growth. Proc Natl Acad Sci U S A (1980) 0.86
New method for exopolysaccharide determination in culture broth using stirred ultrafiltration cells. Appl Microbiol Biotechnol (2001) 0.86
Multiple characterizations of Listeria monocytogenes sensitive and insensitive variants to divergicin M35, a new pediocin-like bacteriocin. J Appl Microbiol (2006) 0.86
Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol (2005) 0.86
Microbial dynamics of co- and separately entrapped mixed cultures of mesophilic lactic acid bacteria during the continuous prefermentation of milk. Enzyme Microb Technol (1997) 0.85
Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol (1997) 0.85
Use of antisense RNA to modulate glycosyltransferase gene expression and exopolysaccharide molecular mass in Lactobacillus rhamnosus. J Microbiol Methods (2005) 0.85
Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. Cytokine (2001) 0.85
[Management of muscle and nerve biopsies: expert guidelines from two French professional societies, Société française de myologie et de l'Association française contre les myopathies]. Rev Neurol (Paris) (2010) 0.84
Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clin Microbiol Infect (2009) 0.84
Incidence of bacteriocinogeny among fresh isolates of Streptococcus mutans. Can J Microbiol (1990) 0.84